Cogent Biosciences (COGT) Other Operating Expenses (2020)
Cogent Biosciences has reported Other Operating Expenses over the past 1 years, most recently at $46.9 million for Q3 2020.
- Quarterly results put Other Operating Expenses at $46.9 million for Q3 2020, changed N/A from a year ago — trailing twelve months through Jun 2021 was $46.9 million (changed N/A YoY), and the annual figure for FY2020 was $46.9 million, changed.
- Other Operating Expenses for Q3 2020 was $46.9 million at Cogent Biosciences.
- Over the last five years, Other Operating Expenses for COGT hit a ceiling of $46.9 million in Q3 2020 and a floor of $46.9 million in Q3 2020.